Showing results (541-550 of 645) with videos related to
Sort By:
Pageof 65
Blood|May 5, 2017
Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphomaJohn Kuruvilla, Michael Savona, Rachid Baz, et al.Gerontology|January 30, 2010
Predicting happiness among centenariansAlex J Bishop, Peter Martin, Maurice MacDonald, et al.Gerontology|January 30, 2010
Social resources and longevity: findings from the Georgia centenarian studyG Kevin Randall, Peter Martin, Maurice McDonald, et al.Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition|June 4, 2010
Cognitive performance in centenarians and the oldest old: norms from the Georgia Centenarian StudyL Stephen Miller, Meghan B Mitchell, John L Woodard, et al.Blood Advances|July 11, 2024
Evaluating the impact of laboratory-based eligibility criteria by race/ethnicity in first-line clinical trials of DLBCLArushi Khurana, Raphael Mwangi, Loretta J Nastoupil, et al.Leukemia & Lymphoma|August 14, 2025
Outcomes of relapsed/refractory peripheral T-cell lymphoma in the modern era: impact of stem cell transplant and novel agentsSeda S Tolu, Caitlin Gribbin, Zhengming Chen, et al.Nature Communications|July 2, 2026
BRG1-mediated suppression of ferroptosis underlies BTK inhibitor resistanceSoo-Yeon Hwang, Xiangao Huang, Helgi Nikolli, et al.British Journal of Haematology|March 18, 2020
The combination of ibrutinib and rituximab demonstrates activity in first-line follicular lymphomaNathan H Fowler, Loretta Nastoupil, Sven De Vos, et al.Seminars in Thrombosis and Hemostasis|May 21, 2019
Use of Viscoelastography in Malignancy-Associated Coagulopathy and Thrombosis: A ReviewMark Walsh, Ernest E Moore, Hunter Moore, et al.Journal of Medical Internet Research|August 2, 2019
Implementation of a Digitally Enabled Care Pathway (Part 1): Impact on Clinical Outcomes and Associated Health Care CostsAlistair Connell, Rosalind Raine, Peter Martin, et al.Pageof 65